Schedule 13G ownership disclosure
RALLYBIO CORP
Common Stock, par value $0.0001 per share · CUSIP: 75120L100
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- VIKING GLOBAL INVESTORS LP
Shares: 4,222,969 · Class: 9.99%
- Viking Global Opportunities Parent GP LLC
Shares: 4,222,969 · Class: 9.99%
- Viking Global Opportunities GP LLC
Shares: 4,222,969 · Class: 9.99%
- Viking Global Opportunities Portfolio GP LLC
Shares: 4,222,969 · Class: 9.99%
- Viking Global Opportunities Illiquid Investments Sub-Master LP
Shares: 4,222,969 · Class: 9.99%
- HALVORSEN OLE ANDREAS
Shares: 4,222,969 · Class: 9.99%
- Ott David C.
Shares: 4,222,969 · Class: 9.99%
- Shabet Rose Sharon
Shares: 4,222,969 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000905148-26-000885
- Form type
- SCHEDULE 13G/A
- Filer
- Rallybio Corp
- CIK
- CIK 1739410
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership